• Return to Headlines

Clovis Oncology Shares Down 75.8% Since SmarTrend's Sell Call (CLVS)

By Nick Russo

SmarTrend identified a Downtrend for Clovis Oncology (NASDAQ:CLVS) on March 25th, 2019 at $23.84. In approximately 6 months, Clovis Oncology has returned 75.76% as of today's recent price of $5.78.

In the past 52 weeks, shares of Clovis Oncology have traded between a low of $4.98 and a high of $35.84 and are now at $5.78, which is 16% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.1% while the 50-day MA has declined 6.8%.

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Clovis Oncology.

Log in and add Clovis Oncology (CLVS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights clovis oncology

Ticker(s): CLVS